Online citations, reference lists, and bibliographies.

Obesity In Kidney Disease.

P. Stenvinkel
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The worldwide obesity epidemic carries not only a considerable increased risk for comorbid complications, such as hypertension, type 2 diabetes, nonalcoholic fatty liver, osteoarthritis, cancer, psychosocial complications, dyslipidemia, cardiovascular disease, and sleep apnea, but also for chronic kidney disease (CKD) and its progression to end-stage renal disease (ESRD). Proper prevention and treatment of obesity in the general population may be one of the most relevant action points in order to prevent the global increase of CKD. Since body mass index is a poor estimate of fat mass distribution in ESRD, nephrologists need to learn to use other measures of fat mass distribution, such as waist-hip ratio. Obesity is associated with better outcomes in inflamed dialysis patients, and current evidence indicates that although the risk of postoperative complications are increased, the outcome of obese patients undergoing renal transplantation are better than in obese dialysis patients who remain on dialysis. The current model that overeating of carbohydrates mixed with a sedentary lifestyle and a resulting asymmetry between energy in and out as the only explanation of the obesity epidemic have been confronted. Recent studies suggest that more complicated coexisting transformations, such as changes in the epigenome, modified neurotransmitter activity, gut dysbiosis, virus infections, and metabolic changes provoked by specific nutrients, may also contribute to overweight status.
This paper references
Differences in clinical and laboratory data of peritoneal dialysis patients selected according to body mass index.
A. Grzegorzewska (2003)
10.1038/ki.2011.114
Higher recipient body mass index is associated with post-transplant delayed kidney graft function.
M. Molnar (2011)
10.1038/ijo.2009.259
Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response
S. E. Perez-Pozo (2010)
10.1152/ajpregu.00195.2008
Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding.
A. Shapiro (2008)
10.1681/ASN.2006091050
Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up.
R. de Mutsert (2007)
10.1097/01.ASN.0000083905.72794.E6
Effects of body size and body composition on survival in hemodialysis patients.
S. Beddhu (2003)
10.1093/AJCN/80.5.1222
Truncal fat mass as a contributor to inflammation in end-stage renal disease.
J. Axelsson (2004)
10.1053/J.AJKD.2005.05.020
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
K. Kalantar-Zadeh (2005)
10.1681/ASN.2010050506
The effect of fructose on renal biology and disease.
R. Johnson (2010)
10.1056/NEJMSA066082
The spread of obesity in a large social network over 32 years.
N. Christakis (2007)
10.1159/000332975
Gut Microbiota and Its Pathophysiology in Disease Paradigms
D. Festi (2011)
10.1177/089686089101100113
The Effect of Body Weight on CAPD Related Infections and Catheter Loss
B. Piraino (1991)
10.1046/J.1523-1755.2003.00287.X
Body size and outcomes on peritoneal dialysis in the United States.
J. Snyder (2003)
10.1055/s-2007-1003340
Influence of hypertonic monosaccharide infusions on the release of plasma arginine vasopressin in normal humans.
J. Wolf (1992)
10.1152/ajpendo.1993.264.5.E730
Effect of sodium intake on insulin sensitivity.
D. S. Donovan (1993)
10.2215/CJN.02250409
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.
S. Navaneethan (2009)
10.1681/ASN.2005111241
Increasing body mass index and obesity in the incident ESRD population.
H. Kramer (2006)
10.2215/CJN.02080310
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients.
Nazanin Noori (2010)
10.1038/sj.ijo.0802300
Diet and body mass index in 38 000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans
E. Spencer (2003)
10.1093/ndt/gfp492
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis.
A. Cordeiro (2010)
10.1093/AJCN/85.3.695
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite.
J. Carrero (2007)
10.1001/jama.2011.1914
Bariatric surgery and long-term cardiovascular events.
L. Sjöström (2012)
10.1038/ejcn.2011.159
Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women
Chad L. Cox (2012)
10.1053/J.AJKD.2007.06.004
Body mass index and mortality in CKD.
M. Madero (2007)
10.7326/0003-4819-144-1-200601030-00006
Body Mass Index and Risk for End-Stage Renal Disease
C. Hsu (2006)
10.1016/j.soard.2008.08.016
Improvement and stabilization of chronic kidney disease after gastric bypass.
J. Alexander (2009)
10.1038/sj.ijo.0802830
Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids
R. Atkinson (2005)
10.1017/S1368980011002138
Consumption of dietary salt measured by urinary sodium excretion and its association with body weight status in healthy children and adolescents.
L. Libuda (2012)
10.1053/AJKD.2003.50059
Demographics and trends in overweight and obesity in patients at time of kidney transplantation.
A. Friedman (2003)
10.1152/ajpregu.1999.276.4.R1046
Fatty acid oxidation affects food intake by altering hepatic energy status.
M. Friedman (1999)
10.1002/bjs.7264
Renal cytokines improve early after bariatric surgery
M. Bueter (2010)
10.1016/S0272-6386(03)00020-9
A central body fat distribution is related to renal function impairment, even in lean subjects.
S. Pinto‐Sietsma (2003)
10.2174/157339906775473626
Chronic inflammation: role of adipose tissue and modulation by weight loss.
T. You (2006)
10.2215/CJN.02720409
Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal.
J. Carrero (2009)
10.1111/j.1467-789X.2009.00677.x
Viral obesity: fact or fiction?
A. Mitra (2010)
10.1172/JCI25151
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.
K. Morino (2005)
10.1126/scitranslmed.3000322
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
P. Turnbaugh (2009)
10.1093/AJCN/86.4.899
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
R. Johnson (2007)
10.1016/j.bbrc.2009.02.145
Effect of glucose and fructose on food intake via malonyl-CoA signaling in the brain.
M. Lane (2009)
10.1681/ASN.2005060638
Obesity and risk for chronic renal failure.
E. Ejerblad (2006)
10.1681/ASN.2006040327
The enlarging body of evidence: obesity and chronic kidney disease.
G. Chertow (2006)
10.1093/AJCN/86.3.633
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality.
Hirokazu Honda (2007)
10.1001/JAMA.292.14.1724
Bariatric Surgery: A Systematic Review and Meta-analysis
H. Buchwald (2004)
10.1210/jc.2009-1590
Mitochondrial function and insulin resistance in overweight and normal-weight children.
A. Fleischman (2009)
10.1177/089686080402400408
Obesity is a Risk Factor for Peritonitis in the Australian and New Zealand Peritoneal Dialysis Patient Populations
S. McDonald (2004)
10.1080/17477160801896754
Could viruses contribute to the worldwide epidemic of obesity?
R. Atkinson (2008)
10.1093/NDT/GFP168
Is there any survival advantage of obesity in Southern European haemodialysis patients
M. Bossola (2009)
10.1046/J.1523-1755.1999.00389.X
Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients.
E. Fleischmann (1999)
10.1097/01.ASN.0000091587.55159.5F
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations.
S. McDonald (2003)
10.1159/000095328
Leptin and renal fibrosis.
G. Wolf (2006)
10.1038/ki.1983.72
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.
B. Brenner (1983)
10.1523/JNEUROSCI.2760-08.2009
Saturated Fatty Acids Produce an Inflammatory Response Predominantly through the Activation of TLR4 Signaling in Hypothalamus: Implications for the Pathogenesis of Obesity
M. Milanski (2009)
10.1093/AJCN.83.3.543
Association of body size with health status in patients beginning dialysis.
K. Johansen (2006)
10.1042/bj2120231
Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia.
A. Rofe (1983)
10.1093/NDT/GFM790
Predictors of new-onset decline in kidney function in a general middle-european population.
R. Obermayr (2008)
10.1111/j.1467-789X.2010.00810.x
The levelling off of the obesity epidemic since the year 1999--a review of evidence and perspectives.
B. Rokholm (2010)
10.7326/0003-4819-140-3-200402030-00007
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
J. Chen (2004)
10.1001/JAMA.291.7.844
Predictors of new-onset kidney disease in a community-based population.
C. Fox (2004)
The nephrotic syndrome in massive obesity: a study by light, immunofluorescence, and electron microscopy.
R. Warnke (1978)
10.1016/S0140-6736(03)15268-3
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
C. Nishida (2004)
10.1001/ARCHINTE.162.21.2428
The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
P. C. Tong (2002)
10.1053/j.ajkd.2008.11.027
Association of body mass index with decline in residual kidney function after initiation of dialysis.
C. Drechsler (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar